(Q37937931)

25 August 2017

1 reference

title

The role of surgery in metastatic breast cancer (English)

1 reference

25 August 2017

metastatic breast cancer

1 reference

Jetske Ruiterkamp

1

1 reference

PubMed ID

21944030

25 August 2017

Miranda F Ernst

series ordinal

2

1 reference

25 August 2017

1 September 2011

1 reference

European Journal of Cancer

25 August 2017

1 reference

25 August 2017

47 Suppl 3

1 reference

25 August 2017

S6-22

1 reference

Does aggressive local therapy improve survival in metastatic breast cancer?

25 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Complete excision of primary breast tumor improves survival of patients with metastatic breast cancer at diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Surgical removal of the primary tumor increases overall survival in patients with metastatic breast cancer: analysis of the 1988-2003 SEER data

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Surgical resection of the primary tumor is associated with increased long-term survival in patients with stage IV breast cancer after controlling for site of metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Association of surgery with improved survival in stage IV breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Surgical resection of the primary tumour is associated with improved survival in patients with distant metastatic breast cancer at diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Stage IV breast cancer in the era of targeted therapy: does surgery of the primary tumor matter?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Improved survival of patients with primary distant metastatic breast cancer in the period of 1995-2008. A nationwide population-based study in the Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Matched pair analyses of stage IV breast cancer with or without resection of primary breast site

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Effects of surgical excision on survival of patients with stage IV breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Breast surgery in stage IV breast cancer: impact of staging and patient selection on overall survival

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Impact of breast surgery on survival in patients with distant metastases at initial presentation: a systematic review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Surgical resection of the primary tumor, chest wall control, and survival in women with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Timing of surgical intervention for the intact primary in stage IV breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Treatment of metastatic breast cancer: looking towards the future

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Circulating tumor cells versus imaging--predicting overall survival in metastatic breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Prognostic significance of circulating tumour cells enumerated after filtration enrichment in early and metastatic breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Surgical removal of primary tumor reverses tumor-induced immunosuppression despite the presence of metastatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Hypothesis: Induced angiogenesis after surgery in premenopausal node-positive breast cancer patients is a major underlying reason why adjuvant chemotherapy works particularly well for those patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Is breast cancer survival improving?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

A role for curative surgery in the treatment of selected patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

[Hepatic resection for breast cancer metastases: results and prognosis (65 cases)]

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Liver metastases from breast cancer: long-term survival after curative resection

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

An attempt to clarify indications for hepatectomy for liver metastases from breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Long-term survival after an aggressive surgical approach in patients with breast cancer hepatic metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Hepatic resection for metastatic breast cancer: prognostic analysis of 34 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Is liver resection justified for patients with hepatic metastases from breast cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

The utility of estrogen receptor, progesterone receptor, and Her-2/neu status to predict survival in patients undergoing hepatic resection for breast cancer metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Surgical treatment of hepatic metastases from breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

International guidelines for management of metastatic breast cancer: can metastatic breast cancer be cured?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Percutaneous radio-frequency ablation of liver metastases from breast cancer: initial experience in 24 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

The use of radiofrequency in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Radiofrequency ablation of liver metastases from breast cancer: results in 14 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Radiofrequency ablation in the management of liver metastases from breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

CT-guided radiofrequency ablation in patients with hepatic metastases from breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Breast cancer liver metastases: US-guided percutaneous radiofrequency ablation--intermediate and long-term survival rates

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Percutaneous MR imaging-guided laser-induced thermotherapy of hepatic metastases.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Breast cancer metastases in liver: laser-induced interstitial thermotherapy--local tumor control rate and survival data

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Repeated chemoembolization followed by laser-induced thermotherapy for liver metastasis of breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Open-configuration MR-guided microwave thermocoagulation therapy for metastatic liver tumors from breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Results of lung metastasectomy from breast cancer: prognostic criteria on the basis of 467 cases of the International Registry of Lung Metastases.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Disease-free survival after resection of lung metastases in patients with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Uncertain benefit from surgery in patients with lung metastases from breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Surgery for pulmonary nodules in breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

The role of surgery in the management of solitary pulmonary nodule in breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Favourable long-term results after surgical removal of lung metastases of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Pulmonary metastases of breast cancer. When is resection indicated?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Clinical features of surgical resection for pulmonary metastasis from breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Prognostic factors for recurrent breast cancer patients with an isolated, limited number of lung metastases and implications for pulmonary metastasectomy.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Surgical treatment for skeletal breast cancer metastases: a population-based study of 641 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

The role of external beam radiotherapy in the management of bone metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Single fraction radiotherapy is efficacious: a further analysis of the Dutch Bone Metastasis Study controlling for the influence of retreatment

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Role of postoperative radiation therapy after stabilization of fractures caused by metastatic disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Management of bone metastases in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Surgical treatment strategies and outcome in patients with breast cancer metastatic to the spine: a review of 87 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Radiotherapeutic management of brain metastases: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Stereotactic radiosurgical treatment of cerebral metastases arising from breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Surgical treatment of 70 patients with brain metastases from breast carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Multimodality therapy in inflammatory breast cancer: is there a place for surgery?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Systemic treatments for inflammatory breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm. Results of a randomized trial in a single centre

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Adjuvant chemo- and hormonal therapy in locally advanced breast cancer: a randomized clinical study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Locally advanced breast cancer: the contribution of cytotoxic and endocrine treatment to radiotherapy. An EORTC Breast Cancer Co-operative Group Trial (10792)

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Adjuvant chemotherapy (CMF) for stage III breast cancer: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Long-term follow-up of a randomized trial on adjuvant chemotherapy and hormonal therapy in locally advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Hormonal therapy prolongs survival in irradiated locally advanced breast cancer: a European Organization for Research and Treatment of Cancer Randomized Phase III Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Primary radiotherapy of breast cancer: treatment results in locally advanced breast cancer and in operable patients selected by positive axillary apex biopsy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Radical radiotherapy alone in non-operable breast cancer: the major impact of tumor size and histological grade on prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

The effect of systemic therapy on local-regional control in locally advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Locally advanced breast cancer: defining an optimum treatment regimen.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Prognostic factors in locally advanced noninflammatory breast cancer. Long-term results following primary chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Inflammatory carcinoma of the breast: treatment results on 107 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Management of locally advanced carcinoma of the breast. II. Inflammatory carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Effectiveness of mastectomy by response to induction chemotherapy for control in inflammatory breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Mastectomy in the management of patients with inflammatory breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

The Centre H. Becquerel studies in inflammatory non metastatic breast cancer. Combined modality approach in 178 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Edema of the arm as a function of the extent of axillary surgery in patients with stage I-II carcinoma of the breast treated with primary radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Influence of adjuvant irradiation on the development of late arm lymphedema and impaired shoulder mobility after mastectomy for carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Results of neoadjuvant chemotherapy and radiation therapy in the breast-conserving treatment of 250 patients with all stages of infiltrative breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Sentinel node biopsy before neoadjuvant chemotherapy for determining axillary status and treatment prognosis in locally advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Axillary staging in the neoadjuvant setting

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Effect of breast-conserving therapy versus radical mastectomy on prognosis for young women with breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Presentation, management and outcome of axillary recurrence from breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Detection, treatment and outcome of axillary recurrence after axillary clearance for invasive breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM). EORTC Breast Cancer Cooperative Group and the Danish Breast Cancer Cooperative Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Prognosis after local recurrence after conservative surgery and radiation for early-stage breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Reoperation for locally recurrent breast cancer in patients previously treated with conservative surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Salvage radiotherapy for local failures of lumpectomy and breast irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Thermoradiotherapy for locally recurrent breast cancer with skin involvement

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

The results of radiation therapy for isolated local regional recurrence after mastectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

The prognostic significance of late local recurrence after breast-conserving therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: Results from five randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Point: Hyperthermia with radiation for chest wall recurrences

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Staging and management of axillary lymph nodes in patients with local recurrence in the breast or chest wall after a previous negative sentinel node procedure

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Lymphatic mapping and sentinel lymph node biopsy for patients with local recurrence after breast-conservation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Sentinel lymph node biopsy for local recurrence of breast cancer after breast-conserving therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

The use of radiotherapy for treatment of isolated locoregional recurrence of breast carcinoma after mastectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Isolated local-regional recurrence following mastectomy for adenocarcinoma of the breast treated with radiation therapy alone or combined with surgery and/or chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Long-term prognosis of patients with local recurrence after conservative surgery and radiotherapy for early breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Radiation therapy for chest wall recurrence of breast cancer after mastectomy in a favorable subgroup of patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Aggressive therapy for locoregional recurrence after mastectomy in stage II and III breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Pattern of dissemination and survival following isolated locoregional recurrence of breast cancer. A prospective study with more than 10 years of follow up

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

Locoregional recurrence of breast cancer following mastectomy: always a fatal event? Results of univariate and multivariate analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2811%2970142-3

7 January 2021

10.1016/S0959-8049(11)70142-3

Identifiers

DOI

1 reference

25 August 2017

1 reference

PubMed ID

21944030